|
Volumn 18, Issue 5, 2001, Pages 328-
|
Anaphylaxis: Quintessence, quarrels, and quandaries
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADRENALIN;
AMITRIPTYLINE;
ANTIDEPRESSANT AGENT;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
GLUCAGON;
HISTAMINE H1 RECEPTOR ANTAGONIST;
HISTAMINE H2 RECEPTOR ANTAGONIST;
IMIPRAMINE;
PLACEBO;
ACUTE DISEASE;
ALGORITHM;
ALLERGIC DISEASE;
ANAPHYLAXIS;
BRADYCARDIA;
CHILD CARE;
CLINICAL TRIAL;
DISEASE SEVERITY;
DOSE CALCULATION;
DRUG POTENTIATION;
DRUG PREFERENCE;
EDITORIAL;
EMERGENCY MEDICINE;
EVIDENCE BASED MEDICINE;
GENERAL PRACTITIONER;
GOOD CLINICAL PRACTICE;
HUMAN;
HYPERTENSION;
IMMUNIZATION;
NURSE;
OUTCOMES RESEARCH;
PRACTICE GUIDELINE;
VACCINATION;
|
EID: 0035689449
PISSN: 13510622
EISSN: None
Source Type: Journal
DOI: 10.1136/emj.18.5.328 Document Type: Editorial |
Times cited : (13)
|
References (14)
|